← Open Payments lookup

MATTHEW BRIGMON: Open Payments

NPI 1609475284 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,665 in 124 payments from 20 companies in 2025. Trend: 2023 $997 · 2024 $2,138 · 2025 $2,665

Food & beverage: $2,665
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP33$677
GlaxoSmithKline, LLC.23$399
GENZYME CORPORATION8$226
Takeda Pharmaceuticals U.S.A., Inc.8$197
Insmed, Inc.7$185
Merck Sharp & Dohme LLC8$149
Regeneron Healthcare Solutions, Inc.4$128
Verona Pharma, Inc.6$123
Viatris Specialty LLC7$118
United Therapeutics Corporation4$117

Products named: DUPIXENT, FASENRA, NUCALA, TEZSPIRE, Arikayce, GLASSIA, Ohtuvayre, TRELEGY ELLIPTA.

Industry payments across SC — which companies pay providers there.